4-Iodo-1-isopropyl-1H-imidazole

Catalog No.: 
ACTBUJ604
CAS No.: 
918643-52-4
Molecular Formula: 
C6H9IN2
Molecular Weight: 
236.06
4-Iodo-1-isopropyl-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$162.00InquiryInquiry
1g95%$495.00InquiryInquiry
5g95%$2450.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Iodo-1-isopropyl-1H-imidazole
IUPAC Name4-iodo-1-isopropyl-1H-imidazole
MDL No.MFCD28166260
Molecular FormulaC6H9IN2
Molecular Weight236.06
SMILESCC(N1C=C(I)N=C1)C
InChI KeyKQUPSESEAGXMQN-UHFFFAOYSA-N
Synonym4-Iodo-1-isopropyl-1H-imidazole
CAS No.918643-52-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTBUJ604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVDPO240 route compound structure diagram
    ACVDPO24071759-89-2In Stock
  4. Then
  5. ACTBUJ604 route product structure diagram
    ACTBUJ604918643-52-4
Inquiry

2. ACTBUJ604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVDPO240 route compound structure diagram
    ACVDPO24071759-89-2In Stock
  4. Then
  5. ACTBUJ604 route product structure diagram
    ACTBUJ604918643-52-4
Inquiry

3. ACTBUJ604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. ACVDPO240 route compound structure diagram
    ACVDPO24071759-89-2In Stock
  4. Then
  5. ACTBUJ604 route product structure diagram
    ACTBUJ604918643-52-4
Inquiry

Comments (0)